logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12313634 B1

PDFFull Text
Date of Patent:
May. 27, 2025

Filed:

Nov. 20, 2018

Methods for prediction and early detection of diabetes

Applicants:

Zora Biosciences Oy, Espoo, FI;

Baker Heart and Diabetes Institute, Melbourne, AU;

Inventors:

Kevin Huynh, Footscray, AU;

Dianna Magliano, St Kilda West, AU;

Jonathan Shaw, North Caulfield, AU;

Mika Hilvo, Helsinki, FI;

Reijo Laaksonen, Lempäälä, FI;

Peter Meikle, Lower Plenty, AU;

Assignees:

ZORA BIOSCIENCES OY, Espoo, FI;

BAKER HEART AND DIABETES INSTITUTE, Melbourne, AU;

Attorney:

MH2 Technology Law Group, LLP

Primary Examiner:

Kathryn Elizabeth Limbaugh

Int. Cl.
CPC ...
G01N 33/68 (2006.01); G01N 33/92 (2006.01); G16H 10/60 (2018.01); G16H 20/10 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01);
U.S. Cl.
CPC ...
G01N 33/6893 (2013.01); G01N 33/92 (2013.01); G16H 10/60 (2018.01); G16H 20/10 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G01N 2405/00 (2013.01); G01N 2800/042 (2013.01); G01N 2800/085 (2013.01);
Abstract

An in vitro method for assessing whether a subject is at risk to develop or is suffering from fatty liver disease comprising: (a) assaying a sample from said subject to determine a concentration of at least one fatty liver biomarker from Group E; (b) assaying a sample from said subject to determine a concentration of at least one fatty liver biomarker from Group F; and (c) determining that the subject is suffering from or is at an increased risk of developing fatty liver disease, if said sample contains an increased combination biomarker value of the at least one fatty liver biomarker from Group E and the at least one fatty liver biomarker from Group F, when compared to a control.

Find Patent Forward Citations

Huynh, Kevin. (2025). Methods for prediction and early detection of diabetes (U.S. Patent No. 12313634). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12313634

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…